Chargement en cours...

Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.

We tested the hypothesis that the gastric H+/K+ adenosine triphosphatase inhibitor, omeprazole, because of its different mode of action and pronounced inhibitory effect on gastric acid secretion, may be more effective in peptic ulcer that is refractory to histamine H2 receptor antagonist treatment t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Bardhan, K D, Naesdal, J, Bianchi Porro, G, Petrillo, M, Lazzaroni, M, Hinchliffe, R F, Thompson, M, Morris, P, Daly, M J, Carroll, N J
Format: Artigo
Langue:Inglês
Publié: 1991
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1379086/
https://ncbi.nlm.nih.gov/pubmed/1673953
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!